Skip to main content
Toggle navigation
Home
Icon Legend
Livestream
Audience Response
Ticketed Session
Special Event
Traducción Española
Closed Captioning
Scientific Program
New & Evolving Topics
Tweets by 2022 AAP National Conference & Exhibition
Back
Favorite
Michael Ohlmeyer, PhD
Founder, Pharmacological Sciences Researcher
Atux Iskay LLC
Abstracts(s):
O1086: Pre-clinical Evidence Supporting Novel Protein Phosphatase 2A (PP2A) Activators as Therapeutics in Hepatoblastoma
Saturday, October 8, 2022
7:18 AM – 7:26 AM
US PDT
.png)
